SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma informs about disclosure

31 May 2023 Evaluate
Mankind Pharma has informed that the following Key Managerial Personnel of the Company are severally authorised for the purpose of determining the materiality of an event or information to the Stock Exchange(s): Rajeev Juneja - Vice Chairman & Managing Director, Sheetal Arora - Chief Executive Officer, Arjun Juneja - Chief Operating Officer, Ashutosh Dhawan - Chief Financial Officer. The following Key Managerial Personnel of the Company are severally authorised for the purpose of dissemination of material event/information to the Stock Exchange Ashutosh Dhawan - Chief Financial Office, Pradeep Chugh - Company Secretary & Compliance Officer.

The above information is a part of company’s filings submitted to BSE.

Mankind Pharma Share Price

2123.20 18.50 (0.88%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×